ID   UBA3_HUMAN              Reviewed;         463 AA.
AC   Q8TBC4; A6NLB5; A8K027; O76088; Q9NTU3;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   10-MAY-2017, entry version 158.
DE   RecName: Full=NEDD8-activating enzyme E1 catalytic subunit;
DE            EC=6.3.2.-;
DE   AltName: Full=NEDD8-activating enzyme E1C;
DE   AltName: Full=Ubiquitin-activating enzyme E1C;
DE   AltName: Full=Ubiquitin-like modifier-activating enzyme 3;
DE            Short=Ubiquitin-activating enzyme 3;
GN   Name=UBA3; Synonyms=UBE1C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal kidney;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ARG-9.
RC   TISSUE=Prostatic adenocarcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-463 (ISOFORM 1), VARIANT ARG-9,
RP   FUNCTION, MUTAGENESIS OF CYS-237, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=10207026; DOI=10.1074/jbc.274.17.12036;
RA   Gong L., Yeh E.T.H.;
RT   "Identification of the activating and conjugating enzymes of the NEDD8
RT   conjugation pathway.";
RL   J. Biol. Chem. 274:12036-12042(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 22-463, AND FUNCTION.
RX   PubMed=9694792; DOI=10.1101/gad.12.15.2263;
RA   Osaka F., Kawasaki H., Aida N., Saeki M., Chiba T., Kawashima S.,
RA   Tanaka K., Kato S.;
RT   "A new NEDD8-ligating system for cullin-4A.";
RL   Genes Dev. 12:2263-2268(1998).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH NAE1.
RX   PubMed=12740388; DOI=10.1074/jbc.M303177200;
RA   Bohnsack R.N., Haas A.L.;
RT   "Conservation in the mechanism of Nedd8 activation by the human
RT   AppBp1-Uba3 heterodimer.";
RL   J. Biol. Chem. 278:26823-26830(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 33-463 IN COMPLEX WITH NAE1;
RP   NEDD8 AND ATP, AND MUTAGENESIS OF ARG-211.
RX   PubMed=14690597; DOI=10.1016/S1097-2765(03)00452-0;
RA   Walden H., Podgorski M.S., Huang D.T., Miller D.W., Howard R.J.,
RA   Minor D.L. Jr., Holton J.M., Schulman B.A.;
RT   "The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis
RT   for selective ubiquitin-like protein activation by an E1.";
RL   Mol. Cell 12:1427-1437(2003).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 24-463 IN COMPLEX WITH NAE1,
RP   AND MUTAGENESIS OF ILE-148; ASP-167; 227-LEU-TYR-228; THR-238; ILE-310
RP   AND 352-TYR--TYR-357.
RX   PubMed=12646924; DOI=10.1038/nature01456;
RA   Walden H., Podgorski M.S., Schulman B.A.;
RT   "Insights into the ubiquitin transfer cascade from the structure of
RT   the activating enzyme for NEDD8.";
RL   Nature 422:330-334(2003).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 33-463 IN COMPLEX WITH NAE1
RP   AND UBE2M, AND MUTAGENESIS OF PHE-65; 160-HIS-ILE-161; PRO-192;
RP   ILE-195; PRO-197; LEU-214; MET-217 AND ILE-331.
RX   PubMed=15361859; DOI=10.1038/nsmb826;
RA   Huang D.T., Miller D.W., Mathew R., Cassell R., Holton J.M.,
RA   Roussel M.F., Schulman B.A.;
RT   "A unique E1-E2 interaction required for optimal conjugation of the
RT   ubiquitin-like protein NEDD8.";
RL   Nat. Struct. Mol. Biol. 11:927-935(2004).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 368-463 IN COMPLEX WITH
RP   UBE2M, AND MUTAGENESIS OF SER-368; GLN-369; LEU-370; THR-412; LEU-415;
RP   VAL-418; ILE-421 AND ARG-424.
RX   PubMed=15694336; DOI=10.1016/j.molcel.2004.12.020;
RA   Huang D.T., Paydar A., Zhuang M., Waddell M.B., Holton J.M.,
RA   Schulman B.A.;
RT   "Structural basis for recruitment of Ubc12 by an E2 binding domain in
RT   NEDD8's E1.";
RL   Mol. Cell 17:341-350(2005).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 368-420 IN COMPLEX WITH
RP   UBE2F.
RX   PubMed=19250909; DOI=10.1016/j.molcel.2009.01.011;
RA   Huang D.T., Ayrault O., Hunt H.W., Taherbhoy A.M., Duda D.M.,
RA   Scott D.C., Borg L.A., Neale G., Murray P.J., Roussel M.F.,
RA   Schulman B.A.;
RT   "E2-RING expansion of the NEDD8 cascade confers specificity to cullin
RT   modification.";
RL   Mol. Cell 33:483-495(2009).
CC   -!- FUNCTION: Catalytic subunit of the dimeric UBA3-NAE1 E1 enzyme. E1
CC       activates NEDD8 by first adenylating its C-terminal glycine
CC       residue with ATP, thereafter linking this residue to the side
CC       chain of the catalytic cysteine, yielding a NEDD8-UBA3 thioester
CC       and free AMP. E1 finally transfers NEDD8 to the catalytic cysteine
CC       of UBE2M. Down-regulates steroid receptor activity. Necessary for
CC       cell cycle progression. {ECO:0000269|PubMed:10207026,
CC       ECO:0000269|PubMed:12740388, ECO:0000269|PubMed:9694792}.
CC   -!- ENZYME REGULATION: Binding of TP53BP2 to the regulatory subunit
CC       NAE1 decreases activity.
CC   -!- PATHWAY: Protein modification; protein neddylation.
CC   -!- SUBUNIT: Heterodimer of UBA3 and NAE1. Interacts with NEDD8, UBE2F
CC       and UBE2M. Binds ESR1 and ESR2 with bound steroid ligand (By
CC       similarity). Interacts with TBATA (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-717567, EBI-717567;
CC       Q96FN4:CPNE2; NbExp=5; IntAct=EBI-717567, EBI-7097057;
CC       O14732:IMPA2; NbExp=5; IntAct=EBI-717567, EBI-725233;
CC       P54727:RAD23B; NbExp=2; IntAct=EBI-717567, EBI-954531;
CC       P61081:UBE2M; NbExp=2; IntAct=EBI-717567, EBI-1041660;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TBC4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TBC4-2; Sequence=VSP_041127;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:10207026}.
CC   -!- MISCELLANEOUS: Arg-211 acts as a selectivity gate, preventing
CC       misactivation of ubiquitin by this NEDD8-specific E1 complex.
CC   -!- SIMILARITY: Belongs to the ubiquitin-activating E1 family. UBA3
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC27648.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL117566; CAB55996.2; -; mRNA.
DR   EMBL; AK002159; BAG51021.1; -; mRNA.
DR   EMBL; AK289392; BAF82081.1; -; mRNA.
DR   EMBL; AC092060; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC109587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW65470.1; -; Genomic_DNA.
DR   EMBL; BC022853; AAH22853.1; -; mRNA.
DR   EMBL; AF046024; AAC27648.1; ALT_INIT; mRNA.
DR   EMBL; AB012190; BAA33144.1; -; mRNA.
DR   CCDS; CCDS2909.1; -. [Q8TBC4-1]
DR   CCDS; CCDS2910.1; -. [Q8TBC4-2]
DR   PIR; T17306; T17306.
DR   RefSeq; NP_003959.3; NM_003968.3. [Q8TBC4-1]
DR   RefSeq; NP_937838.1; NM_198195.1. [Q8TBC4-2]
DR   UniGene; Hs.154320; -.
DR   PDB; 1R4M; X-ray; 3.00 A; B/D/F/H=33-463.
DR   PDB; 1R4N; X-ray; 3.60 A; B/D/F/H=33-463.
DR   PDB; 1TT5; X-ray; 2.60 A; B/D=33-463.
DR   PDB; 1Y8X; X-ray; 2.40 A; B=368-463.
DR   PDB; 1YOV; X-ray; 2.60 A; B/D=22-463.
DR   PDB; 2LQ7; NMR; -; A=369-463.
DR   PDB; 2NVU; X-ray; 2.80 A; B=33-463.
DR   PDB; 3DBH; X-ray; 2.85 A; B/D/F/H=33-463.
DR   PDB; 3DBL; X-ray; 2.90 A; B/D/F/H=33-463.
DR   PDB; 3DBR; X-ray; 3.05 A; B/D/F/H=33-463.
DR   PDB; 3FN1; X-ray; 2.50 A; A=368-463.
DR   PDB; 3GZN; X-ray; 3.00 A; B/D=1-463.
DR   PDBsum; 1R4M; -.
DR   PDBsum; 1R4N; -.
DR   PDBsum; 1TT5; -.
DR   PDBsum; 1Y8X; -.
DR   PDBsum; 1YOV; -.
DR   PDBsum; 2LQ7; -.
DR   PDBsum; 2NVU; -.
DR   PDBsum; 3DBH; -.
DR   PDBsum; 3DBL; -.
DR   PDBsum; 3DBR; -.
DR   PDBsum; 3FN1; -.
DR   PDBsum; 3GZN; -.
DR   ProteinModelPortal; Q8TBC4; -.
DR   SMR; Q8TBC4; -.
DR   BioGrid; 114503; 33.
DR   IntAct; Q8TBC4; 16.
DR   MINT; MINT-1375257; -.
DR   STRING; 9606.ENSP00000354340; -.
DR   ChEMBL; CHEMBL2016430; -.
DR   iPTMnet; Q8TBC4; -.
DR   PhosphoSitePlus; Q8TBC4; -.
DR   BioMuta; UBA3; -.
DR   DMDM; 83305811; -.
DR   EPD; Q8TBC4; -.
DR   MaxQB; Q8TBC4; -.
DR   PaxDb; Q8TBC4; -.
DR   PeptideAtlas; Q8TBC4; -.
DR   PRIDE; Q8TBC4; -.
DR   DNASU; 9039; -.
DR   Ensembl; ENST00000349511; ENSP00000340041; ENSG00000144744. [Q8TBC4-2]
DR   Ensembl; ENST00000361055; ENSP00000354340; ENSG00000144744. [Q8TBC4-1]
DR   GeneID; 9039; -.
DR   KEGG; hsa:9039; -.
DR   UCSC; uc003dno.4; human. [Q8TBC4-1]
DR   CTD; 9039; -.
DR   DisGeNET; 9039; -.
DR   GeneCards; UBA3; -.
DR   HGNC; HGNC:12470; UBA3.
DR   HPA; HPA034873; -.
DR   HPA; HPA034874; -.
DR   HPA; HPA065335; -.
DR   MIM; 603172; gene.
DR   neXtProt; NX_Q8TBC4; -.
DR   OpenTargets; ENSG00000144744; -.
DR   PharmGKB; PA162407622; -.
DR   eggNOG; KOG2015; Eukaryota.
DR   eggNOG; COG0476; LUCA.
DR   GeneTree; ENSGT00550000074831; -.
DR   HOGENOM; HOG000166793; -.
DR   HOVERGEN; HBG082736; -.
DR   InParanoid; Q8TBC4; -.
DR   KO; K10686; -.
DR   OMA; NNASLQM; -.
DR   OrthoDB; EOG091G0B0K; -.
DR   PhylomeDB; Q8TBC4; -.
DR   TreeFam; TF300499; -.
DR   BRENDA; 2.3.2.B5; 2681.
DR   BRENDA; 6.2.1.B9; 2681.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; Q8TBC4; -.
DR   UniPathway; UPA00885; -.
DR   ChiTaRS; UBA3; human.
DR   EvolutionaryTrace; Q8TBC4; -.
DR   GeneWiki; UBE1C; -.
DR   GenomeRNAi; 9039; -.
DR   PRO; PR:Q8TBC4; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000144744; -.
DR   CleanEx; HS_UBA3; -.
DR   ExpressionAtlas; Q8TBC4; baseline and differential.
DR   Genevisible; Q8TBC4; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:LIFEdb.
DR   GO; GO:0016881; F:acid-amino acid ligase activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0016922; F:ligand-dependent nuclear receptor binding; IEA:Ensembl.
DR   GO; GO:0019781; F:NEDD8 activating enzyme activity; IDA:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0007113; P:endomitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0038061; P:NIK/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0045116; P:protein neddylation; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   Gene3D; 3.10.20.260; -; 1.
DR   InterPro; IPR014929; E2_binding.
DR   InterPro; IPR000594; ThiF_NAD_FAD-bd.
DR   InterPro; IPR030468; Uba3.
DR   InterPro; IPR033127; UBQ-activ_enz_E1_Cys_AS.
DR   PANTHER; PTHR10953:SF179; PTHR10953:SF179; 1.
DR   Pfam; PF08825; E2_bind; 1.
DR   Pfam; PF00899; ThiF; 1.
DR   SMART; SM01181; E2_bind; 1.
DR   SUPFAM; SSF69572; SSF69572; 1.
DR   PROSITE; PS00865; UBIQUITIN_ACTIVAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell cycle; Complete proteome; Ligase; Nucleotide-binding;
KW   Polymorphism; Reference proteome; Ubl conjugation pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    463       NEDD8-activating enzyme E1 catalytic
FT                                subunit.
FT                                /FTId=PRO_0000194941.
FT   NP_BIND     100    124       ATP. {ECO:0000269|PubMed:14690597}.
FT   NP_BIND     148    171       ATP. {ECO:0000269|PubMed:14690597}.
FT   REGION       53     70       Interaction with UBE2M N-terminus.
FT   REGION      157    161       Interaction with UBE2M N-terminus.
FT   REGION      192    217       Interaction with UBE2M N-terminus.
FT   REGION      227    229       Interaction with NEDD8.
FT   REGION      242    248       Interaction with NAE1.
FT                                {ECO:0000269|PubMed:12740388}.
FT   REGION      292    295       Interaction with NAE1.
FT                                {ECO:0000269|PubMed:12740388}.
FT   REGION      331    338       Interaction with UBE2M N-terminus.
FT   REGION      352    357       Interaction with NEDD8.
FT   REGION      368    463       Interaction with UBE2M core domain.
FT   ACT_SITE    237    237       Glycyl thioester intermediate.
FT   SITE        211    211       Determines specificity for NEDD8.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ       8     21       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041127.
FT   VARIANT       9      9       K -> R (in dbSNP:rs17852113).
FT                                {ECO:0000269|PubMed:10207026,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_023945.
FT   MUTAGEN      65     65       F->G: Reduces affinity for UBE2M.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN     148    148       I->A: No effect on NEDD8 adenylation.
FT                                {ECO:0000269|PubMed:12646924}.
FT   MUTAGEN     160    161       HI->AA: Reduces affinity for UBE2M.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN     167    167       D->A: Abolishes NEDD8 adenylation.
FT                                {ECO:0000269|PubMed:12646924}.
FT   MUTAGEN     192    192       P->A: Reduces affinity for UBE2M; when
FT                                associated with A-195 and A-197.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN     195    195       I->A: Reduces affinity for UBE2M; when
FT                                associated with A-192 and A-197.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN     197    197       P->A: Reduces affinity for UBE2M; when
FT                                associated with A-192 and A-195.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN     211    211       R->Q: Abolishes specificity for NEDD8.
FT                                {ECO:0000269|PubMed:14690597}.
FT   MUTAGEN     214    214       L->A: Reduces affinity for UBE2M; when
FT                                associated with A-217.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN     217    217       M->A: Reduces affinity for UBE2M; when
FT                                associated with A-214.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN     227    228       LY->DD: Strongly reduces NEDD8
FT                                adenylation.
FT                                {ECO:0000269|PubMed:12646924}.
FT   MUTAGEN     237    237       C->S: Abolishes thioester intermediate
FT                                formation. {ECO:0000269|PubMed:10207026}.
FT   MUTAGEN     238    238       T->A: No effect on NEDD8 adenylation;
FT                                impairs thioester intermediate formation.
FT                                {ECO:0000269|PubMed:12646924}.
FT   MUTAGEN     310    310       I->A: No effect on NEDD8 adenylation or
FT                                thioester intermediate formation; impairs
FT                                NEDD8 transfer to UBE2M.
FT                                {ECO:0000269|PubMed:12646924}.
FT   MUTAGEN     331    331       I->A: Reduces affinity for UBE2M.
FT                                {ECO:0000269|PubMed:15361859}.
FT   MUTAGEN     352    357       YTYTFE->ATATA: Abolishes NEDD8
FT                                adenylation.
FT                                {ECO:0000269|PubMed:12646924}.
FT   MUTAGEN     368    368       S->P: Impairs NEDD8 transfer to UBE2M.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN     369    369       Q->P: No effect on NEDD8 transfer to
FT                                UBE2M. {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN     370    370       L->P: Impairs NEDD8 transfer to UBE2M.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN     412    412       T->A: Impairs NEDD8 transfer to UBE2M.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN     415    415       L->A: Impairs NEDD8 transfer to UBE2M.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN     418    418       V->A: Impairs NEDD8 transfer to UBE2M.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN     421    421       I->A: Impairs NEDD8 transfer to UBE2M.
FT                                {ECO:0000269|PubMed:15694336}.
FT   MUTAGEN     424    424       R->A: No effect on NEDD8 transfer to
FT                                UBE2M. {ECO:0000269|PubMed:15694336}.
FT   CONFLICT    146    146       N -> Y (in Ref. 1; CAB55996).
FT                                {ECO:0000305}.
FT   CONFLICT    271    271       D -> G (in Ref. 1; CAB55996).
FT                                {ECO:0000305}.
FT   TURN         35     38       {ECO:0000244|PDB:1TT5}.
FT   HELIX        39     46       {ECO:0000244|PDB:1TT5}.
FT   HELIX        62     68       {ECO:0000244|PDB:1TT5}.
FT   STRAND       72     75       {ECO:0000244|PDB:1TT5}.
FT   HELIX        80     90       {ECO:0000244|PDB:1TT5}.
FT   STRAND       96    100       {ECO:0000244|PDB:1TT5}.
FT   HELIX       106    108       {ECO:0000244|PDB:1TT5}.
FT   TURN        109    111       {ECO:0000244|PDB:1TT5}.
FT   HELIX       117    119       {ECO:0000244|PDB:1TT5}.
FT   HELIX       124    135       {ECO:0000244|PDB:1TT5}.
FT   STRAND      142    146       {ECO:0000244|PDB:1TT5}.
FT   HELIX       148    150       {ECO:0000244|PDB:1TT5}.
FT   HELIX       153    156       {ECO:0000244|PDB:1TT5}.
FT   STRAND      160    164       {ECO:0000244|PDB:1TT5}.
FT   HELIX       169    181       {ECO:0000244|PDB:1TT5}.
FT   STRAND      185    188       {ECO:0000244|PDB:1TT5}.
FT   STRAND      189    191       {ECO:0000244|PDB:1R4M}.
FT   HELIX       192    194       {ECO:0000244|PDB:1TT5}.
FT   STRAND      198    204       {ECO:0000244|PDB:1TT5}.
FT   STRAND      207    213       {ECO:0000244|PDB:1TT5}.
FT   TURN        215    217       {ECO:0000244|PDB:1TT5}.
FT   HELIX       221    227       {ECO:0000244|PDB:1TT5}.
FT   HELIX       236    241       {ECO:0000244|PDB:1TT5}.
FT   HELIX       246    255       {ECO:0000244|PDB:1TT5}.
FT   HELIX       257    260       {ECO:0000244|PDB:1TT5}.
FT   HELIX       275    291       {ECO:0000244|PDB:1TT5}.
FT   HELIX       299    306       {ECO:0000244|PDB:1TT5}.
FT   HELIX       314    333       {ECO:0000244|PDB:1TT5}.
FT   STRAND      341    346       {ECO:0000244|PDB:1TT5}.
FT   STRAND      348    350       {ECO:0000244|PDB:1TT5}.
FT   STRAND      352    356       {ECO:0000244|PDB:1TT5}.
FT   TURN        365    367       {ECO:0000244|PDB:1TT5}.
FT   STRAND      372    376       {ECO:0000244|PDB:3FN1}.
FT   STRAND      377    379       {ECO:0000244|PDB:1R4M}.
FT   HELIX       382    391       {ECO:0000244|PDB:1Y8X}.
FT   TURN        393    395       {ECO:0000244|PDB:3FN1}.
FT   STRAND      401    406       {ECO:0000244|PDB:1Y8X}.
FT   STRAND      409    414       {ECO:0000244|PDB:1Y8X}.
FT   HELIX       419    430       {ECO:0000244|PDB:1Y8X}.
FT   STRAND      431    433       {ECO:0000244|PDB:1Y8X}.
FT   HELIX       434    436       {ECO:0000244|PDB:1Y8X}.
FT   HELIX       437    440       {ECO:0000244|PDB:1R4M}.
FT   STRAND      443    447       {ECO:0000244|PDB:1Y8X}.
FT   STRAND      451    453       {ECO:0000244|PDB:1YOV}.
FT   STRAND      455    460       {ECO:0000244|PDB:1Y8X}.
SQ   SEQUENCE   463 AA;  51852 MW;  4C16DC0EEDE31A76 CRC64;
     MADGEEPEKK RRRIEELLAE KMAVDGGCGD TGDWEGRWNH VKKFLERSGP FTHPDFEPST
     ESLQFLLDTC KVLVIGAGGL GCELLKNLAL SGFRQIHVID MDTIDVSNLN RQFLFRPKDI
     GRPKAEVAAE FLNDRVPNCN VVPHFNKIQD FNDTFYRQFH IIVCGLDSII ARRWINGMLI
     SLLNYEDGVL DPSSIVPLID GGTEGFKGNA RVILPGMTAC IECTLELYPP QVNFPMCTIA
     SMPRLPEHCI EYVRMLQWPK EQPFGEGVPL DGDDPEHIQW IFQKSLERAS QYNIRGVTYR
     LTQGVVKRII PAVASTNAVI AAVCATEVFK IATSAYIPLN NYLVFNDVDG LYTYTFEAER
     KENCPACSQL PQNIQFSPSA KLQEVLDYLT NSASLQMKSP AITATLEGKN RTLYLQSVTS
     IEERTRPNLS KTLKELGLVD GQELAVADVT TPQTVLFKLH FTS
//
